# John Voith

> John Voith is the CEO and co-founder of InStride Health, a Boston-based virtual specialty care company built to scale a proven hospital model for treating pediatric anxiety and OCD through insurance. A repeat healthcare entrepreneur who previously founded teledentistry company Virtudent and rose from intern to general manager at athenahealth, he pairs an operator's obsession with measurement with a mission-first conviction that evidence-based care should reach every family that needs it.

- **Role:** CEO and Co-Founder at InStride Health
- **Organizations:** InStride Health, Virtudent, athenahealth, IMS Health
- **Nationality:** American
- **Education:** Bachelor of Arts, Harvard University, MBA, Health Care Administration, The Wharton School, University of Pennsylvania, Master of Public Administration, Harvard Kennedy School, Program on Value-Based Health Care Delivery, Harvard Business School
- **Known for:** Co-founded and leads InStride Health, raising $56M total to scale insurance-covered pediatric anxiety and OCD care, Built a model where 97% of program graduates experience clinical improvement and 98% would recommend the program, Previously co-founded teledentistry company Virtudent and served as its CEO

## Career timeline

- **2007** — Began career as a strategy consultant and analyst at IMS Health
- **2010** — Joined athenahealth, eventually rising from intern to general manager
- **2017** — Co-founded Virtudent, serving first as COO and later CEO
- **2021** — Co-founded InStride Health and became CEO
- **2022** — Launched InStride Health publicly with $26M to scale the McLean Anxiety Mastery Program
- **2024** — InStride closed a Series B, bringing total funding to $56M

## Achievements

- Co-founded and leads InStride Health, raising $56M total to scale insurance-covered pediatric anxiety and OCD care
- Built a model where 97% of program graduates experience clinical improvement and 98% would recommend the program
- Previously co-founded teledentistry company Virtudent and served as its CEO
- Rose from intern to general manager at athenahealth, leading interoperability across record sharing, ordering and scheduling

## Latest updates

- **2022-10** — InStride Health launched publicly with $26M to scale the McLean Anxiety Mastery Program for pediatric anxiety and OCD.
- **2024-03** — InStride Health closed a Series B funding round, bringing total capital raised to $56M.

## Links

- Website: https://instride.health
- LinkedIn: http://www.linkedin.com/in/johnvoith

---

Profile page: https://yespress.io/john-voith
Published by YesPress — https://yespress.io
Last updated: 2026-06-04